Bio Protocol vs Jito — how do they compare? Bio Protocol trades at Rp429.33 (market cap Rp974,32M, Rp148,57M 24h volume), while Jito trades at Rp9,696 (market cap Rp4,9T, Rp368,61M 24h volume). The key difference: Jito is far larger — about 5029.1× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Jito's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Jito for 29 Days on average.
| BIO | JTO | |
|---|---|---|
Market Cap | Rp974,32M | Rp4,9T |
Volume (24h) | Rp148,57M | Rp368,61M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 509,8M JTO |
Typical Hold Time | 18 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Jito is trading at Rp10,083 with a market cap of Rp5.14T, showing a bullish technical signal driven by moving averages. The current price is near the pivot point of Rp10,059, with support at Rp9,673 and resistance at Rp10,286. RSI_6 indicates overbought conditions at 92.32, while ADX signals a strong trend. No major protocol updates or ecosystem news were found recently.
Overall outlook is cautiously optimistic due to bullish technicals, but high RSI suggests potential pullback. Key opportunities include strong trend momentum; major risks involve overbought volatility and lack of recent fundamental catalysts. Investors should monitor support levels for entry points.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Jito Network is a major contributor to the Solana ecosystem through its JitoSOL liquid staking pool, and its collection of MEV products. With Jito, users can stake their SOL tokens through the Jito Stake Pool, receiving the JitoSOL token, which is a unique asset that not only provides liquidity but also combines staking rewards and MEV rewards.
Read more on JTO →